Purchases and Sales Made in Q3 2022 in Unicycive Therapeutics, Inc. (UNCY)
This table provides information about the institutional ownership of Unicycive Therapeutics, Inc. (UNCY) during Q3 2022. The information is specifically focused on institutions that hold shares of Unicycive Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 16, 2022
Q3 2022
|
Captrust Financial Advisors
Raleigh, NC |
BUY
|
- |
18.8KNew |
$10.7K - $16.9K
|
18.8K
$14.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
1.9K+ 17.27% |
$1.08K - $1.71K
|
12.9K
$10.1K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
10+ 0.19% |
$5.7 - $9
|
5.18K
$4.04K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
9+ 25.0% |
$5.13 - $8.1
|
45
$35.1
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-3.3K- 73.5% |
$1.88K - $2.97K
|
1.19K
$928
|
|
|
Nov 10, 2022
Q3 2022
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-19.1K- 2.62% |
$10.9K - $17.2K
|
711K
$554K
|
|
|
Nov 14, 2022
Q3 2022
|
Board Of Trustees Of The Leland Stanford Junior University
Stanford, CA |
SELL
|
- |
-185K- 74.55% |
$105K - $166K
|
63K
$49.2K
|